Harmony Biosciences (HRMY) Tops Q1 EPS by 16c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
Harmony Biosciences Reports First Quarter 2021 Results and Business Updates
May 11, 2021 8:02 AM EDTWAKIX® (pitolisant) Total Revenue of $59.7 Million for First Quarter 2021
Achieves Profitability with $7.4 Million Net Income
Conference Call and Webcast to be Held Today at 8:30 a.m. ETÂ
PLYMOUTH MEETING, Pa., May 11, 2021 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Harmony or the Company) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs, today reported financial results and business updates for the first quarter ended March 31, 2021.
... More